Hubert P, Giannini S L, Vanderplasschen A, Franzen-Detrooz E, Jacobs N, Boniver J, Delvenne P
Department of Pathology, University Hospital of Liège, CHU Sart Tilman, 4000 Liège, Belgium.
FASEB J. 2001 Nov;15(13):2521-3. doi: 10.1096/fj.00-0872fje. Epub 2001 Sep 17.
Although human papillomavirus (HPV) antigens are expressed in a majority of (pre)neoplastic lesions (squamous intraepithelial lesions; SILs) of the uterine cervix, progression to invasive cancer may occur, which suggests that the presentation of viral antigens to the immune system is deficient in some SILs. To determine whether professional antigen-presenting cells die in SILs, we assayed for the apoptosis of immature dendritic cells (DC) in organotypic cultures of HPV-transformed keratinocytes, which reproduce many features of in vivo observed SILs. Unexpectedly, the infiltration of organotypic cultures by DC specifically induced the apoptosis of HPV+ tumor cells, whereas DC were not affected. In the same conditions and in coculture experiments, apoptosis was not observed in normal keratinocytes. The induction of apoptosis required membrane contacts between DC and HPV-transformed keratinocytes. Although the HPV+cell lines were sensitive to the effects of TRAIL, soluble TRAILR2-Fc did not block the DC-induced apoptosis. Furthermore, although FasL and Fas were detected on DC and HPV+ cell lines, respectively, functional analysis revealed that this pathway is not responsible for the apoptosis induced by the DC. All together these results suggest that DC may be at the interface between innate and adaptive immunity by inducing the apoptosis of (pre)neoplastic cells.
尽管人乳头瘤病毒(HPV)抗原在子宫颈的大多数(癌前)肿瘤病变(鳞状上皮内病变;SILs)中表达,但仍可能进展为浸润性癌,这表明在某些SILs中,病毒抗原向免疫系统的呈递存在缺陷。为了确定专职抗原呈递细胞在SILs中是否死亡,我们检测了HPV转化的角质形成细胞的器官型培养物中未成熟树突状细胞(DC)的凋亡情况,该培养物重现了体内观察到的SILs的许多特征。出乎意料的是,DC对器官型培养物的浸润特异性诱导了HPV+肿瘤细胞的凋亡,而DC未受影响。在相同条件下和共培养实验中,正常角质形成细胞未观察到凋亡。凋亡的诱导需要DC与HPV转化的角质形成细胞之间的膜接触。尽管HPV+细胞系对TRAIL的作用敏感,但可溶性TRAILR2-Fc并未阻断DC诱导的凋亡。此外,尽管分别在DC和HPV+细胞系上检测到了FasL和Fas,但功能分析表明该途径与DC诱导的凋亡无关。所有这些结果表明,DC可能通过诱导(癌前)肿瘤细胞凋亡而处于固有免疫和适应性免疫的界面。